Vertex Pharmaceuticals
VRTX
VRTX
492 hedge funds and large institutions have $24.5B invested in Vertex Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 207 increasing their positions, 164 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $28.5B → $24.5B (-$4B)
36% less call options, than puts
Call options by funds: $86.7M | Put options by funds: $135M
Holders
492
Holding in Top 10
8
Calls
$86.7M
Puts
$135M
Top Buyers
| 1 | +$198M | |
| 2 | +$182M | |
| 3 | +$178M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$171M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$161M |
Top Sellers
| 1 | -$289M | |
| 2 | -$158M | |
| 3 | -$116M | |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$107M |
| 5 |
O
OppenheimerFunds
New York
|
-$76.8M |